SULLIVAN CHRISTOPHER RYAN (Interim CFO) received a stock award from AVALO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/26/2026ACC: 0001810417-26-000014
Officer· Interim CFO
Since Apr 2020
+39.90K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
39.90K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+39.90K
Price / share
—
Trade value
—
% of position
9432.6%
5/21/2026
423.00→40.32K
Total
Net shares
+39.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | A · Award | +39.90K | — | — | 9432.6% | 423.00 | 40.32K |
| Total | +39.90K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported